Introduction

An interview with Kirsten Stett, co-founder of DC-VC Bio, exploring their investment thesis and portfolio companies focused on computational biology and Deep Tech solutions for therapeutics, agriculture, and industrial biotech, as well as the impact of AI in the life sciences industry.